The Chanhassen-based company plans to use the funds on a randomized trial of its “sonodynamic therapy” for glioblastoma.

From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

Globus Medical’s board of directors authorized a share repurchase program of up to $500 million of the company’s outstanding common stock. Timing and number of repurchased shares will be determined by ...

What Happened? A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5% ...

Medical alert systems make accessing help in an emergency easy. Whether you fall and injure yourself or experience another type of medical situation, these systems can dispatch help from an ...

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after market close. Here’s what to look for. Globus Medical beat analysts’ revenue expectations ...

Chobani’s billionaire founder is going all-in on being American-made. CEO Hamdi Ulukaya broke ground this week on a new state-of-the-art facility in upstate New York that will produce one ...

<a href="http://www.koin.com">www.koin.com</a> California Gas Prices Could Skyrocket 75%, Newsom Is Warned Megyn Kelly now has the third-biggest right-wing podcast as ...

NEW YORK (May 6, 2025) — Bulletproof Your Marketplace: Strategies for Protecting Your Digital Platform by Jeremy H. Gottschalk is available today on Amazon. The book is published with Forbes ...

The upcoming report from Globus Medical (GMED) is expected to reveal quarterly earnings of $0.74 per share, indicating an increase of 2.8% compared to the year-ago period. Analysts forecast ...